SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-055872
Filing Date
2024-05-08
Accepted
2024-05-08 17:00:28
Documents
14
Period of Report
2024-05-08
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20240508.htm   iXBRL 8-K 45735
2 EX-99.1 crnx-ex99_1.htm EX-99.1 43296
3 GRAPHIC img113038668_0.jpg GRAPHIC 6091
4 GRAPHIC img113038668_1.jpg GRAPHIC 6091
  Complete submission text file 0000950170-24-055872.txt   224300

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20240508.xsd EX-101.SCH 23892
17 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20240508_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 24927268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)